CCSVI Exploring the Relationship:

Slides:



Advertisements
Similar presentations
Kirsty Duncan PhD. WHAT ARE THE GOALS FOR CARE OF PEOPLE WITH MS, AND PREVENTION OF MS IN THE NEXT GENERATION? “To help patients live with the disease"?
Advertisements

B2 Keeping Healthy REVISION. How do our bodies resist infection? Harmful microorganisms reproduce quickly inside the body, because it is w______ and they.
Varicose Veins: More Than Just a Cosmetic Problem
For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold Andrew R. Forauer, MD Michael Bazylewicz, BS Kristine A. Pattin, BS Interventional Radiology.
Single Center Experience with Drug Eluting Stents for Infrapopliteal Occlusive Disease in Patients with Critical Limb Ischemia: Mid-term follow up Robert.
Copyright © 2009, Society for Vascular Surgery ®. All rights reserved. Your Vascular Health is a Matter of Life and Limb.
-George Kresovich -Justin Goodridge
Ischemic cardiopathy. Ischemic cardiopathy is a term used to describe patients whose heart can no longer pump enough blood to the rest of their body due.
Interventional Radiologists- Where will they go next?
Multiple Sclerosis The Malaysian Saga Dr Rahul Chavan, MD Medical Director, Malaysia.
STROKE Dr Muhammah Ashraf Assistant Professor Medicine
Multiple Sclerosis Definition: Multiple sclerosis (MS) is a disease of the central nervous system (CNS); it damages the protective coating around the.
Short-term outcomes after endovascular treatment for chronic cerebrospinal venous insufficiency (CCSVI) in patients with multiple sclerosis Kenneth Mandato,
Isolated Thrombolysis for DVT DVT Treatment with the Trellis ® Peripheral Infusion System Manufacturer’s Registry Report Gerard J. O’Sullivan MD Mahmood.
Lower Extremity Venous Disease: Peripheral Venous Insufficiency
Cardiovascular Diseases Eric Huang Engineering World Health.
By Amanda Rossi. Multiple Sclerosis, also known as ‘MS,’ is a long- term disease that effects the brain and spinal cord. This impacts the functions of.
Interventional Radiology in Cancer Patients C. Douglas Edmondson, M.D., FACR C. Douglas Edmondson, M.D., FACR Interventional and Diagnostic Radiologist.
Better understanding the brain, the heart, the problems and the solutions Steven Harrington, MDWilma Agnello-Dimitrijevic, MD Cardiothoracic SurgeonNeurologist.
HEART HEALTH. LET’S SEE WHAT YOU KNOW ABOUT THE HUMAN HEART!
Radiology is the use of radiation for different types of imaging which include x-rays Imaging simply means creating an image of the inner body of a dense.
Angina and MI.
Multiple Sclerosis (MS) By: Morgan Farr Biology 1010.
Interventional Radiology Minimum Access – Maximum Result.
VASCULAR & INTERVENTIONAL RADIOLOGY. INTERVENTIONAL RADIOLOGY Interventional radiology also known as Image-Guided Surgery or Surgical Radiology, is a.
Preventive behaviors can reduce the risk for cardiovascular disease and stroke.
Heart Disease Heart Disease-is any condition that reduces the strength of functioning of the heart and blood vessels. Heart disease is the leading cause.
“Outpatient Arteriography and Arterial Intervention in Octogenarians. Is It Safe?” George G. Hartnell Baystate Medical Center Springfield, MA Safe at Any.
What is Multiple Sclerosis (MS)? an unpredictable disease of the central nervous system, which can range from relatively benign to somewhat disabling.
Adam Percey. What is it?  MS is a disease of the central nervous system.  What happens is the myelin sheaths around the axon of a nerve fade away. These.
Understanding Heart Disease In this lesson, you will Learn About… Different types of heart disease. How heart disease is treated. What you can do to reduce.
Endovascular management of CCSVI: Single Center Experience Hector Ferral, MD, George Behrens, MD, Yanki Tumer, MD, Tameem Souman, MD.
بسم الله الرحمن الرحيم Prepared by: Ala ’ Qa ’ dan Supervisor :mis mahdia alkaunee Cor pulmonale.
Unit 4.4 Review PBS.
Angiography By: M.Abid (EE ) Irfan-ullah(EE )
Terminology in Health Care and Public Health Settings Unit 5 Cardiovascular System Component 3/Unit 51 Health IT Workforce Curriculum Version 1/Fall 2010.
Chapter 14 Lesson 2 Heart Disease Next >> Teacher’s notes are available in the notes section of this presentation.
Look Closer Improving understanding of the leading cause of heart attack and stroke.
Multiple Sclerosis Jesse Mohoric and Sarah Davis.
Disorders of the Cardiovascular System
Pathophysiology BMS 243 Vascular Diseases Lecture IV Dr. Aya M. Serry
Angiography and Interventional Radiography Chapter 17.
Testing In Heart Failure Answers, Answers, Answers… Shashank Desai, MD Medical Director, Heart Failure / Transplant Program Inova Fairfax Hospital Falls.
Dr C Raghu Interventional Cardiologist
Interventional Radiology Minimum Access – Maximum Result.
Cardiovascular Disease Cardiovascular Stents. Cardiovascular Stents Presented by:  Introduction - Becky Rentz  The Problem – Kim Noah  Significance.
Heart Disease What is Heart Disease? Heart disease is a condition that weakens the heart and blood vessels. Heart Disease kills more Americans than any.
Lifestyle diseases, Genetic diseases, Chronic diseases.
TREATING CARDIOVASCULAR DISEASES. Target: I will be able to describe treatments cardiovascular diseases Pg. 59 Treatments for Cardiovascular Diseases:
Cardiopulmonary Disorders. Common Cardiac Disorders Coronary Artery Disease Myocardial Infarction (MI) Heart Murmurs/Valvular Heart Disease Congestive.
Multiple Sclerosis. What is MS? This is a chronic and often disabling disease in which the body’s immune system (t-cells) attacks the central nervous.
POLISH EXPERIENCE IN CCSVI TREATMENT Marian Simka EuroMedic Department of Vascular & Endovascular Surgery Katowice Poland.
CATEGORY: IMMUNE DYSFUNCTION Multiple Sclerosis Lindsay Nicholson, University of Bristol, UK [ Multiple sclerosis (MS) is.
We analyze the neurological symptoms and provide special neurology treatment. Neurologist, Moeen Din, M.D treats stroke, headache, migraine etc.
Peripheral Artery Disease (PAD)
Interventional Radiology (IR) - what is that? Wojciech Ćwikiel MD
CRT 2012 Venous Disease.
L.Grozdinski and I.Petrov, M.Iloska,M.Pavlova
CCSVI: can we justify the procedure at this time?
CCSVI Richard F. Neville, MD Professor of Surgery
Recanilization of Central Venous Total Occlusions
Feasibility and safety of endovascular treatment for chronic cerebrospinal venous insufficiency in patients with multiple sclerosis  Tommaso Lupattelli,
What is Interventional Radiology?
Treating Cardiovascular Diseases
Cardiovascular Disease (2:22)
Stenting of the venous outflow in chronic venous disease: Long-term stent-related outcome, clinical, and hemodynamic result  Peter Neglén, MD, PhD, Kathryn.
Clinical case of a swollen limb Emphasis on diagnosis
A new approach to carotid angioplasty and stenting with transcervical occlusion and protective shunting: why it may be a better carotid artery intervention 
From Theory to Practice: Creating a limb Preservation Center
Nicolas Mouawad, MD, Chief and Medical Director, Vascular and Endovascular Surgery, McLaren Bay Region A Tale of two lesions.
Presentation transcript:

CCSVI Exploring the Relationship: Chronic Cerebrospinal Venous Insufficiency & Multiple Sclerosis James F. McGuckin, M.D. Director, Philadelphia Vascular Institute Founder, Vascular Access Centers www.vascularaccesscenters.com

Introduction: Dr. James McGuckin Double major in Mechanical Engineering and Pre-Medical from the University of Notre Dame in 1983, M.D. from Hahnemann University in 1987, Masters Degree in Bioengineering at the University of Pennsylvania in 1990, Diagnostic Imaging in 1995, and Fellowship in Interventional Radiology at the Hospital of the University of Pennsylvania in 1996. Many invited lectures annually in the USA and Internationally. Founded Philadelphia Vascular Institute, Rex Medical, and Vascular Access Centers (www.vascularaccesscenters.com). I am a full-time practicing Interventional Radiologist and am licensed in over 20 states in the USA. I primarily see Western Canadian citizens in Seattle and Eastern Canadians in Philadelphia and New Jersey. Research interests include: over 150 medical device patents, CCSVI, Cardiovascular Systems, Endoscopy and Endosurgery, Peripheral Arterial Disease, Limb Salvage, Percutaneous Oncologic Therapy, End Stage Renal disease and recanalization of Central Venous Occlusion using RF ablation. I have collaborated with Drs. Lindsay Machan (BC), C.S. HO (Toronto General) and Dr. Sandy McDonald (Ontario) and I fully believe that the Canadian physicians will be up to the clinical challenge of treating the patients with MS from the vascular health perspective.

Autoimmune Theory Commonly held beliefs about MS For more than fifty years, medical doctors and scientists have believed and adhered to the theory that MS is an autoimmune disease. Autoimmune disease occurs when an overactive immune system—the system that naturally protects the human body against disease—mistakenly attacks a healthy part of the body as if it is a dangerous pathogen (like a virus) that must be destroyed. Proponents of the autoimmune theory believe that the disease develops when the immune system mounts an aggressive, misguided attack against the myelin sheath that insulates and protects the nerves of the Central Nervous System (CNS). They have yet to identify exactly why the immune system would initiate the attack. *Medicine changes and evolves- when I was in medical school Peptic Ulcer disease was caused by acid not bacteria, Non-A Non-B Hepatitis became Hepatitis C, Breast Cancer had an incidence of 1:11 later to become 1:7, and CABG (Coronary Artery Bypass) was the mainstay- not the fall back plan if all else fails. This will be review for some, but it does give context for CCSVI.

CCSVI – The Vascular Theory How is the CCSVI theory different? The CCSVI theory as it relates to MS does not contradict the fact that there is autoimmune activity and myelin damage within most MS lesions. It simply helps to explain how and why this activity and damage got its start- and why the MS symptoms follow similar patterns. According to the CCSVI theory, deformities in the veins that drain the CNS disrupt proper outflow of deoxygenated blood from the brain and spinal column- this is why we look for stenoses involving the drainage of the Jugulars, Azygous, Renal, and Pelvis. These deformities include malformed valves, significant narrowing, and membranous tissue or webbing inside the vein. When the blood leaving the brain encounters these deformities, it often refluxes back into the brain or stays too long within the brain because of delayed drainage.

“The Call” and The Hippocratic Oath Can you open the blocked vein in my neck? The first patient- “can you open the blocked vein in my neck?” “I think I can open your blocked vein, but I don’t know what it will do to your MS symptoms.” I was naive. An amazing experience-five wheelchair bound patients getting out of the chair and walking in our office in one week. The artist who could only see a circle on the wall- the circle that became a clock with numbers and minute hash marks between the numbers while still on the procedure table. The doctor speaks and nystagmus ceases. After three years of silence the physician-patient with MS said his three children’s names and sang Happy Birthday to his wife. His 10 years of constantly roving brainstem controlled eye movement stopped post-procedure and his eyes are now steady and controlled. Having a patient discharged from a nursing home and going home again- a joy to any caregiver. A patient on the table saying-“I see colors again.” “The pain in my head is gone.” These treated deformities include malformed valves, significant narrowing, and membranous tissue or webbing inside the vein.

Correlative Vascular Theory in Liver Cirrhosis -Budd-Chiari Disease Vascular outflow obstruction from the liver leads to portal hypertension (localized high venous blood pressure) causing cirrhosis secondary to iron deposition and inflammation. This venous disease (narrowing) is treated by venous angioplasty and stenting if needed. (Remember this picture you will see it again.) This will be review for some, but it does give context for CCSVI.

Prevalence of CCSVI “Many different groups from all over the world clearly showed by the means of gold standard catheter venography that the prevalence of CCSVI in MS [patients] is more than 90% of the cases studied (USA, Greece, Poland, Jordan, etc.)” *International Society for Neurovascular Disease, Bologna 2010

Treating CCSVI What can be done today? The structural problems of CCSVI can be treated effectively through balloon venoplasty—angioplasty of the veins. Ballooning disrupts venous irregularities by increasing the diameter of the vein. Increased diameter leads to improved blood flow, which helps reduce venous insufficiency.

Catheter entry-point Femoral access vein Access the patient easily through the Left Femoral vein with ultrasound guidance.

CCSVI: -Extremely safe -Conscious sedation Rapid Recovery Azygos systems Internal jugular veins Renal Veins Femoral access vein Renal veins Iliac veins CCSVI: -Extremely safe -Conscious sedation Rapid Recovery Check and treat the venous narrowings

The Right Internal Jugular is selected and studied by venogram- the narrowing is treated by veno/balloon angioplasty and the collaterals or side-street vessels go away because the resistance to flow is gone through valve disruption.

Dramatic dilation by balloon angioplasty of the Left Internal Jugular narrowing with resolution of the parallel vessels showing the resistant to flow by the abnormal valve being treated.

The picture on the left is the Left Internal Jugular vein again- the picture on the right is the Budd-Chiari venogram- upside down. Venous narrowing look the same regardless of location.

The Azygous vein behind the heart with dramatic congestion because of an outflow venous narrowing treated successfully with angioplasty

47 yo MSx 17 yrs pre-CCSVI procedure

Secondary Progressive MS pre-CCSVI

24 hours post- procedure

4 days post-procedure

CCSVI – Summary I have personally studied hundreds of patients with MS. They all have had CCSVI. The majority of these patients are citizens of Canada, and most of them are enrolled in the Hubbard Registry. None of these MS patients were normal on venography and all had truncal venous abnormalities. These deformities include malformed valves, significant narrowing, and membranous tissue or webbing inside the vein. Over 80% of patients have had a positive response to the treatment with a reduction in their symptoms. The focus of MS research should include discovering the etiology of MS, improving treatments for MS patients, evaluating the safety and efficacy of treating the vascular abnormalities associated with CCSVI/MS, and developing therapies that augment and preserve the improvements developed through endovascular treatment.